Effect of nebulized eucalyptus on ventilator associated pneumonia

Phase 3

• Conditions: Ventilator associated pneumonia.; Unspecified bacterial pneumonia; J15.9

• Registration Number: IRCT20180107038251N3
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

18-65 years old
oral intubation
Under ventilation for at least 3 days and up to 14 days
lack of pulmonary infection, sepsis, pulmonary thromboembolism, atelectasis, Gastrointestinal inflammatory disease and severe hepatic disease.
no allergy to herbal compounds

Exclusion Criteria

nasal intubation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ventilator associated pneumonia. Timepoint: Ventilator associated pneumonia are measured on fifth, ninth day and before extubation. Method of measurement: Measurement of variables is based on Modified Clinical Pulmonary Infection Score (MCPIS) checklist. The instrument includes five criteria including temperature, white blood cell count, tracheal secretion , oxygenation, chest radiography, each score is 0 to 2, and total score is 10. If total score is equal to or greater than 6, pneumonia is detected.